Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: A randomized controlled study (JAPAN-IDDM)

Diabetes Research and Clinical Practice

Volumn 55, Issue 2, 2002, Pages 113-121

  Katayama, Shigehiro ^a   Kikkawa, Ryuichi ^b   Isogai, Syo ^c   Sasaki, Nozomu ^a   Matsuura, Nobuo ^d   Tajima, Naoko ^e   Urakami, Tatsuhiko ^f   Uchigata, Yasuko ^g   Ohashi, Yasuo ^h  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIHON UNIVERSITY   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

Captopril; Diabetes mellitus; Imidapril

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; IMIDAPRIL; IMIDAPRILAT; PLACEBO; PRODRUG; THIOL GROUP;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROTECTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD PRESSURE; CAPTOPRIL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMIDAZOLES; IMIDAZOLIDINES; MALE; PLACEBOS;

EID: 0036140366     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00289-3     Document Type: Article

References (23)

1. An overview of dialysis treatment in Japan (as of 31 December 1998)
2. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment
3. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis
4. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
5. Renal protective effect of enalapril in diabetic nephropathy
6. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience
7. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection
8. Efficacy of captopril in postponing in normotensive insulin dependent diabetic patients with microalbuminuria
9. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
10. Long term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study
11. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
12. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus
13. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
14. Pharmacological studies on (4S)-1-methyl-{(2S)}-2[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino]propionyl}-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor. 1. ACE inhibitory and anti-hypertensive activities
15. Pharmacological studies on TA-6366, a new ACE inhibitor: II. Effect of long-term administration from the pre-hypertensive stage on blood pressure, relative heart weight and ACE activity of various tissues in spontaneously hypertensive rats (SHRs)
16. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy
17. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
18. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
19. A prospective study of blood pressure and incidence of end-stage renal disease in 332 544 men
20. Achievment and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group
21. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS38
22. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
23. Pathophysiology of progressive nephropathies